Results 51 to 60 of about 6,002 (227)

Markerless tumor tracking for lung SBRT with the Radixact Synchrony system: Initial experience and short‐term clinical outcomes

Journal of Applied Clinical Medical Physics, Volume 26, Issue 12, December 2025.
Abstract Purpose To report the initial clinical experience with the radixact synchrony lung with respiratory (LWR) technique in stereotactic body radiotherapy (SBRT) for lung tumors, focusing on feasibility, dosimetric performance, and early clinical outcomes using both standard and extended fractionation regimens.
Evren Ozan Goksel, Zeynep Ozen, Seckin Gunduz, Artunc Ture, Halil Kucucuk, Alptekin Arifoglu, Evrim Tezcanli, Ufuk Abacioglu, Meric Sengoz   +8 more
wiley   +1 more source

A review on radiochromic film dosimetry in radiation therapy

Journal of Applied Clinical Medical Physics, Volume 26, Issue 12, December 2025.
Abstract Radiochromic films (RCFs) are ubiquitous in radiation oncology clinical and research settings to measure the radiation dose over a two‐dimensional (2D) area due to their high spatial resolution, water‐equivalency, and relative ease‐of‐use. Upon irradiation, the constituent monomers of the active layer of RCFs undergo polymerization, leading to
Arash Darafsheh, Hamid Ghaznavi
wiley   +1 more source

TP029/#1459 Prospective multi-institutional phase III trial of standard of care therapy with or without sterotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC, KGOG 3064/KROG 2204) [PDF]

, 2022
Yong Bae Kim, Hwa Kyung Byun, Jung‐Yun Lee, Sokbom Kang, Jae‐Hoon Kim, Jae‐Weon Kim, Young Tae Kim   +6 more
openalex   +1 more source

Fast and accurate measurement of small field dosimetry using a novel scintillation detector

Journal of Applied Clinical Medical Physics, Volume 26, Issue 12, December 2025.
Abstract Background The most used instruments for small‐field dosimetry have notable limitations, including the need for correction of output factors, limited scanning speeds, and challenges in alignment for percentage depth dose (PDD) measurements, particularly for extremely small fields.
Yiding Han, Jingzhu Xu, Yao Hao, Baozhou Sun   +3 more
wiley   +1 more source

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy, 2019
Michael Mix,1 Sean Tanny,1 Tamara Nsouli,1 Ryan Alden,1 Rishabh Chaudhari,2 Russell Kincaid,1 Paula F Rosenbaum,3 Jeffrey A Bogart,1 Paul Aridgides1 1Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA; 2Department ...
Mix M, Tanny S, Nsouli T, Alden R, Chaudhari R, Kincaid R, Rosenbaum PF, Bogart JA, Aridgides P   +8 more
doaj  

Organs at risk proximity in central lung stereotactic ablative radiotherapy: A comparison of four-dimensional computed tomography and magnetic resonance-guided breath-hold delivery techniques

Physics and Imaging in Radiation Oncology
Higher toxicity rates are associated with stereotactic ablative radiotherapy (SABR) to central lung tumors. Breath-hold (BH) magnetic resonance-guided SABR (MR-SABR) can reduce doses to organs at risk (OAR). We quantified the planning target volumes (PTV)
Nicolas Giraud, Hilâl Tekatli, Famke L. Schneiders, John R. van Sornsen de Koste, Marco Marzo, Miguel A. Palacios, Suresh Senan   +6 more
doaj   +1 more source

Assessing Second‐Line Treatment Strategies and Outcomes in Epidermal Growth Factor Receptor (EGFR) Oncogene‐Driven Stage IV Non‐Small Cell Lung Cancer, Following a First‐Line EGFR‐TKI Therapy

Cancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Oncogene‐driven metastatic non‐small cell lung cancer (mNSCLC) is associated with poor survival outcomes, despite advancements in first‐line tyrosine kinase inhibitor (TKI) therapies. Aims This study aimed to characterise second‐line treatment strategies for epidermal growth factor receptor (EGFR)‐driven mNSCLC, and to evaluate ...
Meghana Maddula, Annelise Decaria, Bea Brown, John Simes, Michael Boyer, Venessa Chin   +5 more
wiley   +1 more source

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

BMC Cancer, 2019
Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose, hypofractionated radiotherapy, and achieves excellent rates of local control for ...
David A. Palma, Robert Olson, Stephen Harrow, Rohann J. M. Correa, Famke Schneiders, Cornelis J. A. Haasbeek, George B. Rodrigues, Michael Lock, Brian P. Yaremko, Glenn S. Bauman, Belal Ahmad, Devin Schellenberg, Mitchell Liu, Stewart Gaede, Joanna Laba, Liam Mulroy, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Andrew Warner, Ben J. Slotman, Tanja D. de Gruijl, Alison Allan, Suresh Senan   +24 more
doaj   +1 more source

Survival Outcomes in Breast Cancer Patients With Metastatic Bone Disease

World Journal of Surgery, Volume 49, Issue 12, Page 3326-3334, December 2025.
To evaluate the survival outcomes of breast cancer patients with metastatic bone disease and to assess whether these patients exhibit different prognoses compared to those with more extensive metastatic involvement. ABSTRACT Objective To evaluate the survival outcomes of breast cancer patients with metastatic bone disease and to assess whether these ...
Gerard J. Hill, Aisling Hegarty, Gavin P. Dowling, Sandra Hembrecht, Gordon R. Daly, Trudi Roche, Eithne Downey, Michael Allen, Colm Power, Nuala Healy, Leonie S. Young, Arnold D. K. Hill   +11 more
wiley   +1 more source

Stereotactic Body Therapy for Urologic Cancers—What the Urologist Needs to Know

Life
Background: stereotactic ablative body radiotherapy (SABR) is a disruptive radiation therapy technique which is increasingly used for the treatment of urologic cancers.
Jasamine Coles-Black, Adib Rahman, Shankar Siva, Joseph Ischia, Marlon Perera, Damien Bolton, Nathan Lawrentschuk   +6 more
doaj   +1 more source